Lilly’s Experimental Diabetes Shot Yields Record Weight Loss in Study - Bloomberg.com
Lilly’s Experimental Diabetes Shot Yields Record Weight Loss in Study  Bloomberg.com Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial  CNBC Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in fir…